Helixgate

Media

Press & Media Access

Helixgate Biotech Review is a high-tech intelligence publication covering the companies, technologies, and capital shaping the future of biotechnology and life sciences.

Media Information

For press credentials, conference coverage, interview requests, and media inquiries, please contact our press office.

Coverage Areas

Industry Positioning

Helixgate operates at the intersection of scientific innovation, computational systems, and capital markets, providing strategic insights and exposure across biotech and pharma.

Media & Event Access

We attend and cover leading biotech events, providing company features, technology highlights, and investor-focused intelligence distribution.

Platform Overview

Helixgate connects biotech companies, pharma organizations, research institutions, and investors through high-tech intelligence and strategic exposure.

Audience & Reach

Delivering high-signal intelligence to decision-makers at the forefront of global innovation.

20,000 - 30,000

Organizations

100,000 - 300,000

Decision-Makers